APA (7th ed.) Citation

Zhang, M., Kim, Y. W., Yang, C. X., Gauvreau, G. M., FitzGerald, J. M., Boulet, L., . . . Singh, A. (2026). Using cell-specific late-phase asthma mRNA biomarkers to repurpose drugs that concurrently reverse disease signatures across multiple immune cell-types. PLoS Computational Biology, 22(4), 1. https://doi.org/10.1371/journal.pcbi.1014081

Chicago Style (17th ed.) Citation

Zhang, Mingming, Young Woong Kim, Chen Xi Yang, Gail M. Gauvreau, J. Mark FitzGerald, Louis-Philippe Boulet, Paul M. O'Byrne, Scott J. Tebbutt, and Amrit Singh. "Using Cell-specific Late-phase Asthma MRNA Biomarkers to Repurpose Drugs That Concurrently Reverse Disease Signatures Across Multiple Immune Cell-types." PLoS Computational Biology 22, no. 4 (2026): 1. https://doi.org/10.1371/journal.pcbi.1014081.

MLA (9th ed.) Citation

Zhang, Mingming, et al. "Using Cell-specific Late-phase Asthma MRNA Biomarkers to Repurpose Drugs That Concurrently Reverse Disease Signatures Across Multiple Immune Cell-types." PLoS Computational Biology, vol. 22, no. 4, 2026, p. 1, https://doi.org/10.1371/journal.pcbi.1014081.